Guo J Y, Zhang L J, Cao C L, Lü Shan, Xu J, Li S Z, Zhou X N
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention; Chinese Center for Tropical Diseases Research; WHO Collaborating Center for Tropical Diseases; National Center for International Research on Tropical Diseases, Ministry of Science and Technology; Key Laboratory of National Health Commission for Parasites and Vector Biology, Shanghai 200025, China.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2020 Oct 19;32(5):511-516. doi: 10.16250/j.32.1374.2020198.
To investigate the implementation of schistosomiasis control activities in China during the coronavirus disease 2019 (COVID-19) epidemic, so as to evaluate the impact of COVID-19 epidemic on the national schistosomiasis control program in China.
On April 2020, 3 counties (districts) were randomly selected from each of the 12 schistosomiasis-endemic provinces (municipality, autonomous region), and a questionnaire survey was conducted to investigate the implementation of schistosomiasis control activities in these counties (districts) from January to March 2020. Then, the impact of the COVID-19 epidemics on the national schistosomiasis control program of China was evaluated using a comparative analysis approach.
Among the 36 counties (cities, districts) sampled from 12 provinces (municipality, autonomous region), 66.67% were at a high and medium risk of COVID-19 epidemics. The implementation of schistosomiasis control activities assignment, human schistosomiasis examination and treatment, snail control with chemical treatment and health education reduced by 44.26% to 91.56% as compared to 2019 during the same time period, and the schistosomiasis control program was more affected by COVID-19 in transmission-controlled provinces. The gross funds invested into the schistosomiasis control program reduced by 23.39% in relative to the expected, while the total expenditure increased by 41.22%. In addition, all 36 surveyed counties (districts) considered that the COVID-19 epidemic had a short-term impact on the schistosomiasis control program, with the most predominant impact on schistosomiasis control activities assignment, human resources and monitoring of endemic situation of schistosomiasis.
The COVID-19 epidemics affect the routine schistosomiasis control program across the endemic-foci of China. Policy and financial support should be strengthened to ensure the completion of the schistosomiasis control program.
调查2019年冠状病毒病（COVID-19）疫情期间中国血吸虫病防治工作的开展情况，以评估COVID-19疫情对中国国家血吸虫病防治规划的影响。
2020年4月，从12个血吸虫病流行省份（直辖市、自治区）中各随机抽取3个县（区），开展问卷调查，调查这些县（区）2020年1月至3月血吸虫病防治工作的开展情况。然后，采用对比分析方法评估COVID-19疫情对中国国家血吸虫病防治规划的影响。
在从12个省（直辖市、自治区）抽取的36个县（市、区）中，66.67%处于COVID-19疫情的高、中风险地区。与2019年同期相比，血吸虫病防治工作任务落实、人群血吸虫病查治、药物灭螺及健康教育等工作的开展率下降了44.26%至91.56%，疫情传播控制省份的血吸虫病防治规划受COVID-19影响更大。血吸虫病防治规划投入总经费较预期减少了23.39%，而总支出增加了41.22%。此外，所有36个被调查县（区）均认为COVID-19疫情对血吸虫病防治规划有短期影响，其中对血吸虫病防治工作任务落实、人力资源及血吸虫病疫情监测影响最大。
COVID-19疫情影响了中国血吸虫病流行区的常规血吸虫病防治规划。应加强政策和资金支持，以确保血吸虫病防治规划的完成。
